How cells stress-out differently

The release of stress hormones triggers a wide variety of different responses in the organism. Some of these responses are controlled by so-called enhancers, regulatory regions in the genome, which influence the activity of genes. Scientists at the...

More

Lymphoma reprograms immune cells to promote its own growth

Instead of defending the body against lymphoma, special immune cells sometimes have the opposite effect. The cancer reprograms the dendritic cells to promote lymphoma tumor growth. Researchers at the Max Delbrück Center for Molecular Medicine in the...

More

Putting black skin cancer to sleep - for good

An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes responsible for erasing...

More

KNAUER joins the United Nations Global Compact movement

The UN Global Compact is the world's largest and most important initiative for responsible corporate governance, involving more than 12,800 companies and organizations from more than 160 countries, 454 of them from Germany. The vision of this United...

More

"Digital Head" Sylvia Thun comes to Berlin

The IT specialist for medicine, Professor Sylvia Thun, will be the new Director for eHealth and Interoperability at Berlin Institute of Health (BIH). The physician and qualified engineer is an expert in national and international IT standards in the...

More

MOLOGEN signs license deal for China and global co-development agreement with ONCOLOGIE for lead compound lefitolimod

• MOLOGEN to receive a EUR 3 million initial payment as well as a EUR 2 million equity investment • Milestone payments of above EUR 100 million and double digit royalties on net sales • Strong support for global development program of lefitolimod,...

More

ProBioGen and TEVA sign license agreement on human artificial lymph node technology

Research License Agreement on Unique Technology to Assess Drug Effects on the Immune System in Vitro.

More

Knauer is one of the most successful empolyers in Germany

A study conducted by the 3.works institute from Düsseldorf confirms, that KNAUER is one of the companies in Germany with the best employer ratings. The results of the study will be published in cooperation with the renowned ZEIT publishing group.

More

BIH Johanna Quandt Professor Ute Scholl discovers genetic cause of rare high blood pressure syndrom

Twenty-five years ago, an unusual inherited form of high blood pressure was first described in an Australian family. Its genetic cause, however, had remained elusive. Using modern sequencing methods, an international research team led by BIH Johanna...

More

Accelerating Digital Health Innovation

Startupbootcamp Digital Health Berlin is now entering its 3rd cycle, and is one of the most serious health accelerators in the continent. How, you ask?

More
Show more items